181 related articles for article (PubMed ID: 32045236)
1. 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
Bhattarai S; Pippel J; Scaletti E; Idris R; Freundlieb M; Rolshoven G; Renn C; Lee SY; Abdelrahman A; Zimmermann H; El-Tayeb A; Müller CE; Sträter N
J Med Chem; 2020 Mar; 63(6):2941-2957. PubMed ID: 32045236
[TBL] [Abstract][Full Text] [Related]
2. α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors.
Bhattarai S; Freundlieb M; Pippel J; Meyer A; Abdelrahman A; Fiene A; Lee SY; Zimmermann H; Yegutkin GG; Sträter N; El-Tayeb A; Müller CE
J Med Chem; 2015 Aug; 58(15):6248-63. PubMed ID: 26147331
[TBL] [Abstract][Full Text] [Related]
3. Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.
Junker A; Renn C; Dobelmann C; Namasivayam V; Jain S; Losenkova K; Irjala H; Duca S; Balasubramanian R; Chakraborty S; Börgel F; Zimmermann H; Yegutkin GG; Müller CE; Jacobson KA
J Med Chem; 2019 Apr; 62(7):3677-3695. PubMed ID: 30895781
[TBL] [Abstract][Full Text] [Related]
4. Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors.
Scortichini M; Idris RM; Moschütz S; Keim A; Salmaso V; Dobelmann C; Oliva P; Losenkova K; Irjala H; Vaittinen S; Sandholm J; Yegutkin GG; Sträter N; Junker A; Müller CE; Jacobson KA
J Med Chem; 2022 Feb; 65(3):2409-2433. PubMed ID: 35080883
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the human ecto-5'-nucleotidase (CD73): insights into the regulation of purinergic signaling.
Knapp K; Zebisch M; Pippel J; El-Tayeb A; Müller CE; Sträter N
Structure; 2012 Dec; 20(12):2161-73. PubMed ID: 23142347
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.
Sharif EU; Kalisiak J; Lawson KV; Miles DH; Newcomb E; Lindsey EA; Rosen BR; Debien LPP; Chen A; Zhao X; Young SW; Walker NP; Sträter N; Scaletti ER; Jin L; Xu G; Leleti MR; Powers JP
J Med Chem; 2021 Jan; 64(1):845-860. PubMed ID: 33399453
[TBL] [Abstract][Full Text] [Related]
7. 2-Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors.
Schäkel L; Mirza S; Pietsch M; Lee SY; Keuler T; Sylvester K; Pelletier J; Sévigny J; Pillaiyar T; Namasivayam V; Gütschow M; Müller CE
Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100300. PubMed ID: 34697820
[TBL] [Abstract][Full Text] [Related]
8. Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production.
Du X; Moore J; Blank BR; Eksterowicz J; Sutimantanapi D; Yuen N; Metzger T; Chan B; Huang T; Chen X; Chen Y; Duong F; Kong W; Chang JH; Sun J; Zavorotinskaya T; Ye Q; Junttila MR; Ndubaku C; Friedman LS; Fantin VR; Sun D
J Med Chem; 2020 Sep; 63(18):10433-10459. PubMed ID: 32865411
[TBL] [Abstract][Full Text] [Related]
9. A domino reaction of 3-chlorochromones with aminoheterocycles. Synthesis of pyrazolopyridines and benzofuropyridines and their optical and ecto-5'-nucleotidase inhibitory effects.
Miliutina M; Janke J; Hassan S; Zaib S; Iqbal J; Lecka J; Sévigny J; Villinger A; Friedrich A; Lochbrunner S; Langer P
Org Biomol Chem; 2018 Jan; 16(5):717-732. PubMed ID: 29303198
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action.
Geoghegan JC; Diedrich G; Lu X; Rosenthal K; Sachsenmeier KF; Wu H; Dall'Acqua WF; Damschroder MM
MAbs; 2016; 8(3):454-67. PubMed ID: 26854859
[TBL] [Abstract][Full Text] [Related]
11. The metabolism of ecto-5'-nucleotidase (CD73) inhibitor-α,β-methylene adenosine diphosphate in BALB/c mice.
Tomczyk M; Mierzejewska P; Slominska EM; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2018; 37(12):709-716. PubMed ID: 30623751
[TBL] [Abstract][Full Text] [Related]
12. Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR Approach.
Bhujbal SP; Hah JM
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884548
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of WO2017098421: GSK's benzothiazine compounds as CD73 inhibitor filings.
Gong YP; Wan RZ; Liu ZP
Expert Opin Ther Pat; 2018 Feb; 28(2):167-171. PubMed ID: 29166791
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidase.
Ripphausen P; Freundlieb M; Brunschweiger A; Zimmermann H; Müller CE; Bajorath J
J Med Chem; 2012 Jul; 55(14):6576-81. PubMed ID: 22731815
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73.
Beatty JW; Lindsey EA; Thomas-Tran R; Debien L; Mandal D; Jeffrey JL; Tran AT; Fournier J; Jacob SD; Yan X; Drew SL; Ginn E; Chen A; Pham AT; Zhao S; Jin L; Young SW; Walker NP; Leleti MR; Moschütz S; Sträter N; Powers JP; Lawson KV
J Med Chem; 2020 Apr; 63(8):3935-3955. PubMed ID: 32212732
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017-present).
Nocentini A; Capasso C; Supuran CT
Expert Opin Ther Pat; 2021 Oct; 31(10):867-876. PubMed ID: 33909515
[TBL] [Abstract][Full Text] [Related]
17. CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.
Dumontet C; Peyrottes S; Rabeson C; Cros-Perrial E; Géant PY; Chaloin L; Jordheim LP
Eur J Med Chem; 2018 Sep; 157():1051-1055. PubMed ID: 30176535
[TBL] [Abstract][Full Text] [Related]
18. CD73-TNAP crosstalk regulates the hypertrophic response and cardiomyocyte calcification due to α1 adrenoceptor activation.
Gan XT; Taniai S; Zhao G; Huang CX; Velenosi TJ; Xue J; Urquhart BL; Karmazyn M
Mol Cell Biochem; 2014 Sep; 394(1-2):237-46. PubMed ID: 24894822
[TBL] [Abstract][Full Text] [Related]
19. Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39.
Jeffrey JL; Lawson KV; Powers JP
J Med Chem; 2020 Nov; 63(22):13444-13465. PubMed ID: 32786396
[TBL] [Abstract][Full Text] [Related]
20. 4-Substituted-1,2,3-triazolo nucleotide analogues as CD73 inhibitors, their synthesis, in vitro screening, kinetic and in silico studies.
Ghoteimi R; Braka A; Rodriguez C; Cros-Perrial E; Tai Nguyen V; Uttaro JP; Mathé C; Chaloin L; Ménétrier-Caux C; Jordheim LP; Peyrottes S
Bioorg Chem; 2021 Feb; 107():104577. PubMed ID: 33450542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
